0001127602-24-019998.txt : 20240703
0001127602-24-019998.hdr.sgml : 20240703
20240703131254
ACCESSION NUMBER: 0001127602-24-019998
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240701
FILED AS OF DATE: 20240703
DATE AS OF CHANGE: 20240703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mellion Michelle L
CENTRAL INDEX KEY: 0001923040
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41374
FILM NUMBER: 241099152
MAIL ADDRESS:
STREET 1: PEPGEN INC.
STREET 2: 245 MAIN ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PepGen Inc.
CENTRAL INDEX KEY: 0001835597
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 MARINA PARK DRIVE, SUITE 900
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 703-456-8000
MAIL ADDRESS:
STREET 1: 1 MARINA PARK DRIVE, SUITE 900
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-07-01
0001835597
PepGen Inc.
PEPG
0001923040
Mellion Michelle L
321 HARRISON AVE., 8TH FLOOR
C/O PEPGEN INC.
BOSTON
MA
02118
1
Chief Medical Officer
1
Common Stock
2024-07-01
4
M
0
875
10.21
A
875
D
Common Stock
2024-07-01
4
S
0
875
18.011
D
0
D
Common Stock
2024-07-02
4
M
0
37
10.21
A
37
D
Common Stock
2024-07-02
4
S
0
37
18.07
D
0
D
Stock Option (Right to Buy)
10.21
2024-07-01
4
M
0
875
0
D
2032-06-30
Common Stock
875
79623
D
Stock Option (Right to Buy)
10.21
2024-07-02
4
M
0
37
0
D
2032-06-30
Common Stock
37
79586
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date.
/s/ Noel Donnelly, as Attorney-in-Fact
2024-07-03